Kamada Ltd. KMDA

Updated: 9 Aug 2026

NASDAQ | Biotech | Plasma-derived biopharmaceuticals

No signal published yet

We already track Kamada and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Kamada free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Plasma-derived biopharmaceuticals
We're already tracking Kamada Ltd. — here are the latest events we've registered

Recent News

  • On July 20, 2026, Kamada announced a three-year sales agreement expected to generate approximately $50 million to supply source plasma from its Texas collection centers to a leading biopharmaceutical company, with shipments starting in the fourth quarter of 2026. Additionally, on August 5, 2026, the company announced that it will release its financial results for the second quarter of 2026 on August 12, 2026.

What Firelda Watch includes for Kamada Ltd.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Kamada Ltd. will be delivered in the same format.

Want to follow Kamada Ltd.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Kamada free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Kamada Ltd. KMDA
Kamada — follow and we'll monitor it
Follow Kamada free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.